Insights

T-Therapeutics’ CEO Allan Bradley shares an overview of the company, our technology and how the team here is seeking to reshape the clinical landscape for patients. In this series of short films, you will have the opportunity to meet some of our fantastic…

Phoebe Lee, a scientist in our Pipeline Expression team, gives a flavour of her day-to-day at T-Therapeutics and her experience in the Cambridge life sciences ecosystem. “Cambridge is part of a really interconnected biotech environment. There's a lot of buzz in the area.”…

Camillo Moschner, PhD a scientist in our Synthetic Biology & Automation department, talks about the importance of bringing biology and engineering closer together and how he works across different teams to make this happen. “One of the beautiful things about my job is…

Amy Li, Director for Drug Discovery at T-Therapeutics. Amy, who was previously Head of Research and Innovation at PetMedix, outlines how learnings gained from the antibody field have informed the OpTiMus® platform and engineering of humanised TCRs. “We believe that we can take advantage…

Michael Casey, Principal Data Scientist at T-Therapeutics outlines how T-Therapeutics is building a soluble TCR ‘factory’ to reliably develop new medications for a range of indications. “I think we've got a great platform, we've got some great indications and we will get it…

What’s it like moving from academia to a lab role at a growing biotech? Ying Ying (Joyce) Tan, a scientist on the Target Discovery team, gives her perspective on the culture of collaboration at T-Therapeutics. “Our company has a very inclusive and diverse…

Senior Director of Translational Medicine Ruben Cabanillas discusses the importance keeping the patient front of the mind at every stage of research and development. Ruben is a physician-scientist with a multidisciplinary background and over 15 years of experience in leading precision medicine initiatives…

T-Therapeutics’ CEO Allan Bradley shares his thoughts on why a diverse, expert team is so vital to the future success of T-Therapeutics. In this final instalment of our employee spotlight series, he explains how it takes a village to create a successful drug,…

Dr David Hung has joined T-Therapeutics as Chairman of its Board of Directors. In this video, which accompanied the announcement, Dr Hung explains his decision: “I have always wanted to be on the cutting-edge of science and transform the practice of medicine. I…